Demographic and clinical features of patients with choroidal melanoma according to treatment modality
| Total | GKR | Enucleation | Brachytherapy | p Value | |
| n | 40 | 15 | 9 | 16 | – |
| Male/female | 22/18 | 10/5 | 5/4 | 7/9 | – |
| Right/left | 18/22 | 9/6 | 4/5 | 5/11 | – |
| Age, years (SD) | 51 (14) | 48 (14) | 55 (14) | 53 (13) | 0.361* |
| Follow-up, months (SD) | 39 (15) | 52 (11) | 36 (14) | 29 (11) | <0.001* |
| Tumour size, mm (SD) | |||||
| LBD | 10.7 (3.1) | 9.7 (2.7) | 12.0 (4.5) | 10.7 (2.2) | 0.536* |
| Height | 6.5 (2.7) | 5.8 (2.5) | 8.5(3.3) | 5.8 (1.8) | 0.099* |
| Classification (7th edition AJCC/UICC), n (%) | |||||
| Stage I | 12 (30.0) | 5 (33.3) | 2 (22.2) | 5 (31.3) | – |
| Stage IIA | 12 (30.0) | 4 (26.7) | 3 (33.4) | 5 (31.3) | – |
| Stage IIB | 6 (15.0) | 1 (6.7) | 1 (11.1) | 4 (25.0) | – |
| Stage IIIA | 3 (7.5) | 2 (13.3) | 1 (11.1) | 0 (0.0) | – |
| Stage IV | 7 (17.5) | 3 (20.0) | 2 (22.2) | 2 (12.4) | – |
| Four-year survival rate (%) | 75 | 78 | 78 | 80 | 0.769† |